BANG — BAG3 (Bcl-2-Associated Athanogene 3)

BAG3 — BCL-2-Associated Athanogene 3

<div class="infobox infobox-gene">
| | |
|---|---| [@bag2007]
| Gene Name | BAG3 | [@bag2012]
| Full Name | BCL-2-Associated Athanogene 3 | [@bag2013]
| Previous Symbols | BANG, BIS | [@bag2014]
| Chromosomal Location | 10q26.11 | [@bag2013a]
| UniProt ID | [O95843](https://www.uniprot.org/uniprot/O95843) | [@bag2014a]
| Protein Family | BAG family molecular chaperone regulators | [@bag2015]
| Molecular Weight | ~57 kDa |
</div>

Overview

BAG3 — BCL-2-Associated Athanogene 3

<div class="infobox infobox-gene">
| | |
|---|---| [@bag2007]
| Gene Name | BAG3 | [@bag2012]
| Full Name | BCL-2-Associated Athanogene 3 | [@bag2013]
| Previous Symbols | BANG, BIS | [@bag2014]
| Chromosomal Location | 10q26.11 | [@bag2013a]
| UniProt ID | [O95843](https://www.uniprot.org/uniprot/O95843) | [@bag2014a]
| Protein Family | BAG family molecular chaperone regulators | [@bag2015]
| Molecular Weight | ~57 kDa |
</div>

Overview

BAG3 (BCL-2-Associated Athanogene 3) is a member of the BAG family of co-chaperones that regulate the Hsp70 family of molecular chaperones. Unlike traditional chaperones, BAG3 does not directly assist in protein folding but instead modulates Hsp70 activity and targets chaperone complexes to specific cellular locations [1](https://pubmed.ncbi.nlm.nih.gov/11013220/). BAG3 is unique among BAG proteins in its ability to form large filamentous structures in response to cellular stress and its specialized role in [autophagy](/entities/autophagy), particularly the selective autophagy of protein aggregates and damaged organelles.

Molecular Function

BAG3 contains multiple functional domains that mediate its diverse cellular functions:

BAG Domain: The C-terminal BAG domain (approximately 110 amino acids) binds to the ATPase domain of Hsp70 family members, modulating their chaperone activity. Unlike other BAG proteins, BAG3 has a secondary Hsp70-binding site, allowing for more complex regulation [2](https://pubmed.ncbi.nlm.nih.gov/14634621/).

WW Domain: The N-terminal WW domain mediates protein-protein interactions with various signaling proteins and transcription factors.

PIXX Domain: This proline-rich domain interacts with SH3 domain-containing proteins, expanding the protein's interaction network.

roles in Cellular Processes:

• Chaperone-assisted Selective Autophagy (CASA): BAG3 coordinates the recognition and targeting of damaged proteins and organelles to autophagosomes for degradation [3](https://pubmed.ncbi.nlm.nih.gov/17603576/).
• Protein Quality Control: BAG3 helps maintain proteostasis by targeting misfolded proteins for degradation.
• Cytoskeletal Organization: BAG3 interacts with the cytoskeleton, particularly Z-discs in muscle cells, where it helps maintain sarcomere integrity.
• Anti-Apoptotic Signaling: Through interactions with Hsp70 and other proteins, BAG3 inhibits [apoptosis](/entities/apoptosis).

Role in Neurodegeneration

Amyotrophic Lateral Sclerosis (ALS)

BAG3 has emerged as a significant player in ALS pathogenesis:

Aggregation and Stress Granules: In ALS, mutant proteins such as SOD1, [TDP-43](/mechanisms/tdp-43-proteinopathy), and FUS accumulate in stress granules and aggresomes. BAG3 is recruited to these structures and plays a dual role - initially protective by facilitating autophagy, but potentially contributing to pathology when overwhelmed [4](https://pubmed.ncbi.nlm.nih.gov/22778007/).

Mutations and Genetic Associations: BAG3 mutations cause a form of dilated cardiomyopathy and myopathy, but variants in BAG3 have also been investigated in ALS. Some studies suggest BAG3 variants may modify ALS risk or progression [5](https://pubmed.ncbi.nlm.nih.gov/23695528/).

Autophagy Regulation: The selective autophagy function of BAG3 becomes particularly important in neurodegenerative diseases where protein aggregation is a hallmark. BAG3 helps target aggregation-prone proteins for autophagic degradation, potentially reducing the burden of toxic protein species.

Parkinson's Disease

In Parkinson's disease, BAG3 may play protective roles:

[Alpha-Synuclein](/proteins/alpha-synuclein) Clearance: BAG3 facilitates the autophagic degradation of alpha-synuclein, the protein that forms Lewy bodies in PD [6](https://pubmed.ncbi.nlm.nih.gov/24042201/). Enhanced BAG3 activity may help clear toxic alpha-synuclein species.

Mitochondrial Quality Control: BAG3 participates in mitophagy, the selective autophagy of damaged mitochondria. Given the central role of mitochondrial dysfunction in PD, this function is particularly relevant [7](https://pubmed.ncbi.nlm.nih.gov/23613355/).

Dopaminergic Neuron Survival: BAG3 expression is upregulated in dopaminergic [neurons](/entities/neurons) in response to various stresses, suggesting a protective response that may fail during disease progression.

Alzheimer's Disease

In Alzheimer's disease, BAG3 has several relevant functions:

Tau Metabolism: BAG3 facilitates the autophagic clearance of [tau protein](/proteins/tau), which accumulates as neurofibrillary tangles in AD [8](https://pubmed.ncbi.nlm.nih.gov/25019411/). This function may help reduce tau burden in neurons.

[Amyloid-Beta](/proteins/amyloid-beta) Toxicity: BAG3 helps protect neurons from amyloid-beta toxicity through chaperone and autophagy functions. Upregulation of BAG3 has been observed in AD brain tissue.

Proteostasis Network: BAG3 is part of the cellular proteostasis network that becomes dysfunctional with aging and in neurodegeneration. Enhancing BAG3 function may help restore proteostasis.

Frontotemporal Dementia

BAG3 is implicated in FTD pathogenesis, particularly in cases with TDP-43 pathology:

TDP-43 Clearance: BAG3 helps target TDP-43 aggregates for autophagic degradation. Dysregulation of this process may contribute to TDP-43 accumulation in FTD [9](https://pubmed.ncbi.nlm.nih.gov/26063265/).

Expression Patterns

BAG3 is expressed in most tissues, with highest expression in cardiac muscle, skeletal muscle, and the pancreas. In the nervous system, BAG3 is expressed in neurons and glial cells throughout the brain and spinal cord. Expression is induced by cellular stress, including heat shock, oxidative stress, and proteasome inhibition.

Therapeutic Implications

BAG3 represents a promising therapeutic target:

Enhancing Autophagy: Small molecules that enhance BAG3 expression or function could boost the cell's capacity to clear toxic protein aggregates.

Modulating Chaperone Activity: Compounds that enhance BAG3-Hsp70 interactions may have therapeutic potential.

Gene Therapy: Viral delivery of BAG3 is being explored in preclinical models of neurodegeneration.

See Also

• [BAG Family Proteins](/proteins/bag-family-proteins)
• [Hsp70 Molecular Chaperones](/proteins/hsp70-family)
• [Autophagy in Neurodegeneration](/mechanisms/autophagy-lysosomal-pathway)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Frontotemporal Dementia](/diseases/frontotemporal-dementia)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving BANG — BAG3 (Bcl-2-Associated Athanogene 3) discovered through SciDEX knowledge graph analysis: